CuraScript Inc. An Express Scripts Co. Revenue and Competitors
Estimated Revenue & Valuation
- CuraScript Inc. An Express Scripts Co.'s estimated annual revenue is currently $73.2M per year.
- CuraScript Inc. An Express Scripts Co.'s estimated revenue per employee is $201,000
Employee Data
- CuraScript Inc. An Express Scripts Co. has 364 Employees.
- CuraScript Inc. An Express Scripts Co. grew their employee count by -3% last year.
CuraScript Inc. An Express Scripts Co.'s People
Name | Title | Email/Phone |
---|---|---|
1 | Contract Manager | Reveal Email/Phone |
2 | Senior Account Manager, Specialty Pharmacy Sales | Reveal Email/Phone |
3 | Oracle DBA | Reveal Email/Phone |
4 | Supervisor, Contract Administration | Reveal Email/Phone |
5 | Staff Accountant Senior | Reveal Email/Phone |
6 | Systems Analysis Advisor | Reveal Email/Phone |
7 | Data Management Strategy & Governance Lead Analyst | Reveal Email/Phone |
CuraScript Inc. An Express Scripts Co. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is CuraScript Inc. An Express Scripts Co.?
The specialty pharmacy business of CuraScript, Inc., an Express Scripts company, is now owned and operated by Accredo Health Group, Inc., an Express Scripts company. To see what's new, visit the Accredo LinkedIn page or accredo.com.
keywords:N/AN/A
Total Funding
364
Number of Employees
$73.2M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $93.3M | 364 | N/A | N/A |
#2 | $150.2M | 364 | 9% | N/A |
#3 | $114.2M | 364 | -1% | N/A |
#4 | $54.6M | 364 | -5% | N/A |
#5 | $122.9M | 364 | 47% | N/A |